25 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances … director compensation policy, as amended from time to time by our Board, which provides for annual retainer fees and/or long-term equity awards for our
S-3
EX-1.2
pfq9jil2v4q3l7 r8p
3 Oct 22
Shelf registration
4:05pm
DEF 14A
kq10n4b6vq6o
28 Apr 22
Definitive proxy
4:07pm
10-K
z5d3sq 7q
3 Mar 22
Annual report
4:31pm
8-K
EX-99.1
vrdm hcbcmak1rqpd
3 Mar 22
Tyra Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights
4:16pm
10-Q
phsh8cha law
3 Nov 21
Quarterly report
4:31pm
424B4
fx07u7ak
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
EX-10.2
br7svbsdy 3b
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
1aajdcz3eld37 wqhxn
9 Sep 21
IPO registration (amended)
6:08am